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Background: Campylobacter jejuni is one of the most important bacterial pathogens causing food-borne illness
worldwide. Crossing the intestinal epithelial barrier and host cell entry by C. jejuni is considered the primary reason
of damage to the intestinal tissue, but the molecular mechanisms as well as major bacterial and host cell factors
involved in this process are still widely unclear.
Results: In the present study, we characterized the serine protease HtrA (high-temperature requirement A) of C. jejuni as
a secreted virulence factor with important proteolytic functions. Infection studies and in vitro cleavage assays showed that
C. jejuni’s HtrA triggers shedding of the extracellular E-cadherin NTF domain (90 kDa) of non-polarised INT-407 and
polarized MKN-28 epithelial cells, but fibronectin was not cleaved as seen for H. pylori’s HtrA. Deletion of the htrA gene in
C. jejuni or expression of a protease-deficient S197A point mutant did not lead to loss of flagella or reduced bacterial
motility, but led to severe defects in E-cadherin cleavage and transmigration of the bacteria across polarized MKN-28 cell
layers. Unlike other highly invasive pathogens, transmigration across polarized cells by wild-type C. jejuni is highly efficient
and is achieved within a few minutes of infection. Interestingly, E-cadherin cleavage by C. jejuni occurs in a limited fashion
and transmigration required the intact flagella as well as HtrA protease activity, but does not reduce transepithelial
electrical resistance (TER) as seen with Salmonella, Shigella, Listeria or Neisseria.
Conclusion: These results suggest that HtrA-mediated E-cadherin cleavage is involved in rapid crossing of the epithelial
barrier by C. jejuni via a very specific mechanism using the paracellular route to reach basolateral surfaces, but does not
cleave the fibronectin receptor which is necessary for cell entry.
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Infections with pathogenic food-borne bacteria constitute
one of the leading causes of morbidity and mortality in
humans. The World Health Organization (WHO) suggests
that the human population worldwide suffers from about
4.5 billion incidences of gastroenteritis annually, causing ap-
proximately 1.8 million deaths [1]. Various Campylobacter
species have been identified as the leading enteric bacterial
infection worldwide [2,3]. Campylobacter jejuni is consid-
ered as a classical zoonotic pathogen, as it is found in the
normal intestinal flora in many birds and mammals. Since
C. jejuni colonizes various food animals, it can contaminate
food products during processing [4]. After ingestion by a
human host, these bacteria use their flagella-driven motility
to colonize the epithelial cells of the ileum and colon. Here,
they can interfere with normal functions in the intestinal
tract, leading to diseases associated with fever, malaise, ab-
dominal pain and watery diarrhoea [2,3]. In addition, a mi-
nority of infected individuals may develop late
complications such as Reiter’s reactive arthritis or Guillain-
Barrè and Miller-Fisher syndromes [5]. There is increasing
evidence showing that C. jejuni disturbs the normal absorp-
tive capacity of the human intestine by damaging epithelial
cell functions, either by cell invasion, the production of
pathogenicity-associated factors or indirectly by triggering
inflammatory responses [3,6-8].
It has been proposed that transmigration across and inva-
sion into intestinal epithelial cells during infection is a major
reason of C. jejuni-triggered tissue damage [2-4]. Investiga-
tion of gut biopsies obtained from infected patients and
in vitro infection experiments of intestinal epithelial cells
indicated that C. jejuni can enter human host cells [9-11].
Campylobacter jejuni expresses various adhesins in
the outer-membrane including CadF, FlpA, JlpA and PEB1
[12-15]. For example, in vitro CadF is a well-known bacterial
factor that binds to fibronectin, an important extracellular
matrix (ECM) protein and bridging factor to integrin recep-
tors [13,16,17]. Maximal bacterial adherence and invasion of
INT-407 intestinal epithelial cells is dependent on CadF and
is associated with tyrosine phosphorylation of paxillin, a focal
adhesion-based scaffolding factor [18]. The expression of
CadF also seems to be required for the stimulation of the
small Rho GTPases Rac1 and Cdc42 via fibronectin and in-
tegrin member β1, that are required for C. jejuni host cell
entry. The signalling pathways involved in the latter process
have been described in detail [19-21]. However, fibronectin
and integrin β1 are basolateral receptor molecules and not
commonly exposed at apical surfaces in the intestine. It is
therefore unclear how C. jejuni gains access to these recep-
tors during infection.
To access deeper tissues and cause short- or long-term
infections in the human body, various pathogenic bacteria,
including Salmonella, Shigella, Listeria or Neisseria, must
overcome the epithelial barrier [22,23]. These importantbacterial pathogens are able to cross polarised intestinal epi-
thelial cells by different mechanisms, known as the para-
cellular and the transcellular routes. Bacteria using the
transcellular route enter host cells at apical surfaces followed
by intracellular trafficking and leave these cells at the baso-
lateral surface. In contrast, bacteria specialised on the para-
cellular route cross the epithelial barrier by passage between
neighbouring epithelial cells and overcome the tight junc-
tions and adherens junctions [24]. In the case of C. jejuni,
the literature is highly controversial. While some groups
reported the paracellular route, others described the trans-
cellular model or a mix of both [25-30]. In general, the host
factors and bacterial factors involved in the transmigration
process of C. jejuni are still unclear [31].
We have recently shown that a closely related pathogen,
Helicobacter pylori, secretes a novel bacterial virulence deter-
minant into the culture supernatant, the serine protease
HtrA [32-34], which is also present in C. jejuni [35-37]. HtrA
proteins constitute a group of heat shock induced serine
proteases that influence the adhesion and invasion properties
of different bacterial pathogens. HtrA proteins typically con-
sist of a signal peptide, a trypsin-like serine protease domain
and one or two protein interaction (PDZ) domains. In
addition, by binding of the PDZ domain in one HtrA mol-
ecule to that in other HtrA molecules, HtrA can build-up to
highly proteolytic active oligomers that also function as a
chaperone [38]. The HtrA protease domain consists of an
active site, called the catalytic triad, which is formed by the
conserved amino acid residues histidine, aspartatic acid and
serine [39]. Many bacterial HtrA proteins are suggested to
be localized in the periplasm and to be involved in quality
control of envelope proteins by degradation of misfolded
proteins as well as prevention of formation of aggregates
[40]. Thus, it was surprising to find that HtrA exhibits the
capability of extracelluar transport in H. pylori [34,41], where
it could cleave host surface molecules. We identified that H.
pylori HtrA directly cleaves the junctional protein and tumor
suppressor E-cadherin and fibronectin on the surface of gas-
tric epithelial host cells. HtrA-mediated cleavage of E-cad-
herin facilitated the loss of the adherence junction complex
leading to the disruption of the epithelial barrier function in
response to H. pylori infection [32] and may also apply to C.
jejuni HtrA [33]. Here, we present the results from a detailed
investigation to determine if C. jejuni HtrA can cleave both
E-cadherin and fibronectin, and whether HtrA protease ac-
tivity is required for transmigration across polarised epithe-
lial cells. Our findings show that C. jejuni can effectively
cross polarised epithelial cells in an HtrA-protease
dependent fashion without affecting TER.
Results & discussion
HtrA protease is conserved in H. pylori and C. jejuni
Recently, HtrA of the gastric pathogen H. pylori was









Figure 1 Analysis of C. jejuni and htrA mutants by scanning
electron microscopy and motility assays. Scanning electron
microscopy revealed that wild-type (wt) C. jejuni and different htrA
mutants of strain 81–176 (A) and NCTC11168 (B) produce intact
bipolar flagella (blue arrows) and only slight morphological
differences. Each bar corresponds to 1 μm.
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cell adhesion protein and tumour-suppressor E-cadherin,
and degrades fibronectin [32]. A sequence alignment of
HtrAs from different C. jejuni and H. pylori strains was per-
formed and revealed a high degree of similarity between
the HtrA domains and protein sequences (Additional file 1:
Figure S1A). We also found that the amino acids in the cata-
lytic triad (histidine, aspartate and serine) are conserved and
at the expected position among these proteins (Additional
file 1: Figure S1B, shaded with yellow). These results suggest
that HtrA’s are highly conserved in various C. jejuni isolates.
We therefore suspected that C. jejuni may also use its HtrA
protease to cross the barrier of polarised epithelial cells.
Analysis of wild-type and htrA mutant C. jejuni by electron
microscopy and motility assays
We first aimed to investigate several htrA mutants in C.
jejuni, including the wild-type (wt) strains 81–176 and
NCTC11168, their isogenic ΔhtrA deletion mutants and
NCTC11168 htrA S197A, a strain with complemented htrA
carrying a point mutation at S197A in the active centre, ren-
dering the protein catalytically inactive [36]. The morphology
of the produced C. jejuni strains was analysed by scanning
electron microscopy (FESEM). Comparison of the C. jejuni
wt strains 81–176 and NCTC11168 with their correspond-
ing htrAmutants revealed some slight differences at the bac-
terial surface, but no major phenoptypical alterations were
noted (Figure 1). In addition, all htrA mutants produced in-
tact bipolar flagella as compared to their wt counterparts
(Figure 1, blue arrows). Studies of all strains by another elec-
tron microscopic method (negative staining) revealed similar
results and thus confirmed our findings (Additional file 1:
Figure S2). Motility assays revealed that both C. jejuni wt
and htrA mutant strains were highly motile, suggesting that
mutation of htrA does not significantly affect this important
pathogenicity property of the bacteria (Figure 2).
HtrA’s of strains 81–176 and NCTC11168 form active
multimers
We tested the assumption that C. jejuni wt strains 81–176
and NCTC11168 can generate proteolytic active HtrA multi-
mers. For this purpose, the wt strains and corresponding iso-
genic ΔhtrA deletion and S197A mutants were grown in
BHI broth medium, followed by casein zymography of total
cell lysates [32]. The results show that the HtrA protein was
not synthesized by the ΔhtrA mutants, whereas HtrA is pro-
duced by the wt and S197A isolates, and only wt C. jejuni
formed caseinolytic active multimers as expected (Figure 3A).
These observations are in agreement with reports on HtrA
in other bacteria such as E. coli where the HtrA multimers
are highly proteolytic active rather than the monomer [38].
The identity of C. jejuni HtrA monomers and multimers
was approved by mass spectrometry of the excised bands as
















































































Figure 2 Different C. jejuni wild-type and htrA mutant strains exhibit high motility. Motility assays were performed for 36 h on agar using
wild-type (wt) C. jejuni and different htrA mutants of strain 81–176 (A) and NCTC11168 (B) and revealed high motility for each strain. (C)
Quantification of motility using the indicated wt and mutant C. jejuni strains. One hundred percent of motility corresponds to the highest
swarming capability presented by C. jejuni wt strain NCTC11168. No significant (ns) differences were seen among the various highly motile strains.
The ΔflaA/B mutant was used motility-deficient a control.
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an anti-CadF blot as loading control (Figure 3A, bottom).Multiple C. jejuni wt strains express active HtrA multimers
To exclude the possibility that HtrA activity is restricted to
the above C. jejuni isolates, we tested a larger collection of
wt strains for their expression of active HtrA proteins. Total
cell lysates from C. jejuni wt RM1221, ATCC43430, TGH-
9011, 1849, 1543/01, 2703/01 and ST3046 were prepared
and analyzed for HtrA protease activities by casein zymogra-
phy. All tested strains expressed the active HtrA multimer
with a molecular size of ~200 kDa, albeit at various extent,
while only faint bands of the monomer at ~53 kDa were
seen (Figure 3B). We could also confirm previous findings
that these native C. jejuni HtrA’s were very similar to recom-
binant H. pylori HtrA forming highly active multimers at the
same size ~200 kDa [33] (Figure 3B, lane 1).C. jejuni secretes HtrA into the culture supernatant where
they form active multimers
The remarkable sequence homology between HtrA’s from H.
pylori and C. jejuni led us to propose that active C. jejuni
HtrA maybe also secreted into the cell culture supernatant
by various strains, similar to its H. pylori counterpart. To test
this hypothesis, C. jejuni wt strains 81–176 and NCTC11168
and its isogenic ΔhtrA deletion mutants were grown in BHI
broth medium and bacteria-free supernatants were prepared,
followed by casein zymography. The results show that the
HtrA proteins from wt C. jejuni were found in the bacterial
culture supernatant fraction where they also form caseinoly-
tic active multimers (Figure 4A and data not shown).
In vitro cleavage properties of purified HtrA’s of C. jejuni
and H. pylori
H. pylori HtrA has recently been shown to cleave the cell


















































































































Figure 3 Detection of proteolytic active HtrA multimers in different C. jejuni wild-type and mutant strains. (A) Total cell lysates of plate-grown
C. jejuni 81–176 wild-type (wt), 81-176ΔhtrA, NCTC11168 wt, NCTC11168ΔhtrA and NCTC11168 htrA S197A were investigated for protease activities
by casein zymography. The position of active monomeric and multimeric HtrA proteins is indicated with arrows. Active monomeric HtrA was only
weakly visible as indicated. The asterisk indicates the inactive HtrA multimer formed by the S197A point mutant. (B) Total cell lysates of the
indicated plate-grown wt strains were separated on non-denaturing gels. Proteolytic active HtrA bands were detected by casein zymography as
described. Purified recombinant H. pylori (Hp) HtrA served as control.
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http://www.gutpathogens.com/content/4/1/3protein fibronectin [32]. Full length E-cadherin has a mo-
lecular weight of about 130 kDa and is composed of a
~90 kDa extracellular domain amino-terminal fragment
(NTF) and a ~40 kDa carboxy-terminal fragment (CTF1)
[32]. To determine whether C. jejuni HtrA can cleave E-
cadherin into specific subfragments recombinant HtrAswas purified. As expected, C. jejuni HtrA had slightly dif-
ferent molecular weight as compared to its H. pylori coun-
terpart, due to the smaller size of the expressed protein
(472 vs. 476 amino acids) (Additional file 1: Figure S3). Re-
combinant C. jejuni HtrA was then incubated with recom-













































































Figure 4 C. jejuni HtrA is secreted into the supernatant, forms proteolytic active multimers and recombinant C. jejuni HtrA cleaves
E-cadherin but not fibronectin. (A) Filtered supernatants of broth-grown wild-type (wt) or htrA mutant C. jejuni (Cj) were subjected to
zymography to detect proteolytic active HtrA multimers. (B) In vitro cleavage of full-length (FL) E-cadherin incubated with purified Cj HtrA
or H. pylori (Hp) HtrA results in shedding of the extracellular N-terminal fragment (NTF). The anti-HtrA blot serves as loading control. (C)
Schematic presentation of the domain structure of full-length human E-cadherin (GenBank accession number CAA78353.1) and the His-tagged NTF
domain used for cleavage assays. E-cadherin consists of five extracellular domains (EC1-EC5) comprising the NTF domain, a transmembrane (TM)
domain and an intracellular domain called C-terminal fragment (CTF). The cleavage site by some host cell proteases is indicated. (D) In vitro cleavage
of the recombinant E-cadherin NTF domain incubated with purified Cj HtrA or Hp HtrA results in cleavage and disappearance of the 90 kDa NTF
fragment. (E) In vitro cleavage assay of fibronectin incubated with purified HtrAs under identical conditions shows that fibronectin can be cleaved by
Hp HtrA but not Cj HtrA. All reactions were incubated for 16 h at 37°C.
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http://www.gutpathogens.com/content/4/1/3of E-cadherin was detected using α-E-cadherin antibodies
recognising the EC5 subunit in the NTF domain. Like its
H. pylori counterpart, it was shown that C. jejuni HtrA
cleaved E-cadherin as monitored by the disappearance of
full-length protein band and increasing amounts of the
~90 kDa NTF domain (Figure 4B/C). In addition, we per-
formed assays with the purified recombinant NTF
domain (amino acids 1–707 followed by a His-tag) show-
ing that this domain disappears upon HtrA cleavage as
shown by anti-E-cadherin and anti-His blots, indicating
that the cleavage site of HtrA is indeed in the extracellular
part of E-cadherin adjacent to the transmembrane domain
(amino acids 711–731) (Figure 4C/D). Interestingly, E-cad-
herin ectodomain cleavage by C. jejuni HtrA was not as ef-
ficient as compared to H. pylori HtrA, but band sizes were
similar, albeit with different intensity. Moreover, H. pylori
HtrA cleaved purified fibronectin into multiple subfrag-
ments, while C. jejuni HtrA did not cleave fibronectin at
all (Figure 4E). These observations suggest that although
HtrA from H. pylori and C. jejuni share substantial0 1 2 4 6 Time in h
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Figure 5 In vivo cleavage of E-cadherin during C. jejuni
infection of non-polarised INT-407 cells and polarised MKN-28
cells. (A) INT-407 cells were infected with C. jejuni NCTC11168
wild-type (wt) strain in a time course. The Western blot shows
changes of cell-associated full-length E-cadherin and reveals the
generation of 90 kDa NTF domain in the supernatant over time.
(B) Polarised MKN-28 cells were infected with C. jejuni 81–176 wt
and htrA mutant strains in a time course. Supernatants were
harvested at each time point, and the E-cadherin NTF fragment
was detected using the indicated antibody. GAPDH expression
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Figure 6 Transmigration characteristics of different bacterial
pathogens across polarised MKN-28 cells using a transwell filter
system. (A) MKN-28 cells were grown to reach monolayers in a
transwell filter system. The cells were then differentiated and TER
was allowed to establish over 14 days as indicated. (B) MKN-28
cells were then infected and CFUs of transmigrated C. jejuni wt
strain 81–176 and some other indicated bacterial pathogens in a
time course. Transmigrated bacteria were harvested from the
bottom chambers, grown on MH plates, and CFUs were
determined in triplicates. (C) TER measurement of infected MKN-28
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Figure 7 Role of HtrA in transmigration of C. jejuni across
polarised MKN-28 cells. (A-C) Differentiated MKN-28 epithelial cells
were grown in a transwell filter system for 14 days, and then
infected with the indicated wild-type (wt) and mutant C. jejuni
strains in the indicated time course. Transmigrated bacteria were
harvested from the bottom chambers, grown on MH plates, and
CFUs were determined in triplicates.
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host substrates. The above experiments were all performed
at 37°C, which is the body temperature of mammalian
hosts. However, since C. jejuni also exhibits host specificity
for avian species (42°C), we tested if HtrA exhibits dif-
ferent cleavage properties at 42°C. Interestingly, the
cleavage patterns were identical between 37°C and 42°C
(Figure 4C/D and Additional file 1: Figure S4).
In vivo cleavage of E-cadherin in C. jejuni infected INT-407
or MKN-28 cells
The next aim was to investigate if C. jejuni HtrA can
cleave E-cadherin during infection in vivo. For this
purpose, E-cadherin-expressing INT-407 and MKN-28
cells were infected with C. jejuni wt strains NCT11168 or
81–176 in a time course for the indicated periods of time
(up to 8 h) and the cleavage of E-cadherin was determined
by immunoblotting. The results show that the overall
amount of full-length E-cadherin dropped down during
infection, but was not eliminated (Figure 5A). In addition,
the signals of the entire 90 kDa NTF increased over time
up to 4 hours and then dropped somewhat, as detected in
the supernatant of infected cells (Figure 5B). In contrast,
significantly reduced E-cadherin ectodomain shedding was
observed during infection with the isogenic ΔhtrA or
S197A mutants (Figure 5 and data not shown). We also
found that fibronectin is not cleaved during C. jejuni
infection (not shown), which is in agreement with the
earlier findings that fibronectin is a major host cell factor
necessary for C. jejuni binding and invasion [13,16,17].
Wild-type C. jejuni transmigrate efficiently across
polarised MKN-28 monolayers but do not reduce TER
Is HtrA activity important for transmigration of C. jejuni
across polarised epithelial cells? To answer this question,
MKN-28 cells were seeded and differentiated in a transwell-
filter system. The transepithelial electrical resistance (TER)
was followed over time and TER values between 140–150
Ω/cm2 were achieved 14 days after reaching confluence
(Figure 6A), similarly to previously reported data [42].
Proper cell monolayers and junction formation were
confirmed by E-cadherin and JAM staining in immunofluor-
escence microscopy [32]. MKN-28 cells were then infected
with C. jejuni and other invasive pathogens as controls, in-
cluding Salmonella typhimurium, Shigella flexneri, Neisseria
gonorrhoeae and Listeria monocytogenes for 0.5 to 24 h, fol-
lowed by determination of the colony forming units (CFU)
in the lower chambers. The results show that C. jejuni trans-
migrated quickly, even much faster than the other pathogens
during the first 30 min and increased up to 200,000 CFU
over time (Figure 6B). At different time points between 2–
24 h, the transmigration rates of C. jejuni were similar to
that of N. gonorrhoeae and L. monocytogenes, but about 3
times lower than S. typhimurium or S. flexneri (Figure 6B).We also noted that S. typhimurium or S. flexneri multiply
quickly in culture medium as compared to the other bacteria
that did not, which can explain these higher CFUs at time
points >24 h. Non-pathogenic E. coli Top10 did not trans-
migrate under the same conditions as expected (data not
shown). Interestingly, the measurement of TER during infec-
tion revealed that while S. typhimurium, S. flexneri, N. gonor-
rhoeae and L. monocytogenes reduced TER substantially over
time, infection with C. jejuni did not influence TER signifi-
cantly (Figure 6C). This indicates that C. jejuni, in contrast
to the other pathogens, does not decrease TER. Thus, C.
jejuni does not induce a permanent opening of the cell-to-
cell junctions in order to induce its transmigration.
C. jejuni ΔhtrA and S197A point mutants have a strong
defect in transmigration
To finally investigate if the expression of HtrA is import-
ant for triggering transmigration of the bacteria across a
polarised epithelium, MKN-28 cells were grown and dif-
ferentiated as described above, followed by infection with
C. jejuni wt strains 81–176 or NCTC11168 and their
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both ΔhtrA mutants exhibited a strong defect in transmi-
gration as compared to wt C. jejuni (Figure 7A/B). In
addition, C. jejuni expressing the protease-inactive S197A
point mutant and a flagellar mutant (ΔflaA/B) were also
widely deficient in transmigration, while a ΔcadF mutant
showed similar transmigration rates at the 4 h time point
(Figure 7B/C). These observations suggest that secreted
HtrA of C. jejuni and its protease activity, but also the
flagellar-driven motility play crucial roles in crossing the
epithelial barrier by this pathogen.
Conclusions
The intestinal mucosa in the human intestine forms a
tight barrier, which protects against host invasion by
commensals, non-pathogenic microbes residing in the
intestinal lumen. Some enteric pathogenic bacteria,
such as Salmonella, Shigella, or Listeria, have specific
tissue-invading properties and can physically breach the
intestinal mucosal barrier [43-45]. In general, these
bacterial pathogens can translocate via a paracellular
route or a transcellular route. A well studied example is
Salmonella enterica serovar Typhimurium which can
cross the intestinal barrier preferentially by entering M
cells, although they can also enter and pass through
epithelial cells of the intestinal tract in vivo and in cultured
polarized epithelial cells in vitro [46-48]. However, very little
is known about C. jejuni transmigration. Previous work has
revealed that C. jejuni can translocate across Caco-2 and
other polarized cell monolayers without a concomitant loss
in TER [25,49-51], indicating that C. jejuni can cross a given
polarised cell monolayer whose integrity, however, remains
intact. In contrast, other research groups reported on a
time-dependent decrease of TER caused by C. jejuni
infection, while the bacterial factor(s) triggering a reduction
in TER were not addressed [52-54]. Thus, there are some
conflicting data in the literature and a consensus is yet to be
reached among investigators as to the mechanism of
translocation.
Our previous data suggested that HtrA chaperone
activity plays a major role in C. jejuni host cell binding,
whereas HtrA protease activity mainly affected invasion
[36]. Novel data presented in this work show that HtrA
from C. jejuni can be secreted into the cell culture
supernatant during bacterial growth or during infection.
In addition, it was shown that C. jejuni can cross polarised
epithelial monolayers very rapidly. The first viable transmi-
grated wt C. jejuni CFU were detected after 15–30 min
(Figure 6 and data not shown). In contrast, C. jejuni
invasion of different host cell types was commonly
observed at much later time points and was obvious
between 4–6 hours or later during infection [18-21,55,56].
These facts alone already indicate that transmigration of
C. jejuni exclude the transcellular route as a majormechanism in MKN-28 cells, which would of course take
much longer time until the first bacteria reach the
basolateral compartment. Instead, our findings strongly
argue for the paracellular route mainly used by C. jejuni
81–176 and NCTC11168. Moreover, it was found that
deletion of htrA or complementation with a protease-
inactive S197A mutant exhibited a strongly reduced
transmigration potential, indicating that HtrA’s protease
activity indeed plays a role in this process. In addition, all
htrA mutants described here expressed flagella and were
highly motile. Thus, we describe here the first C. jejuni
mutants with very high motility, but having very low
transmigration and invasion potential, thus behaving like a
classical avirulent ΔflaA/B mutant.
In addition, evidence was presented that recombinant
HtrA from C. jejuni can cleave-off in vitro and during
infection in vivo the NTF domain from E-cadherin, a
major adherens junctional protein, while it leaves the re-
ceptor molecule fibronectin uncleaved. Thus, cleavage of
E-cadherin may be involved in C. jejuni transmigration. The
exact cleavage site(s) in E-cadherin, however, are yet un-
known and should be investigated in future studies. In
addition, the total amount of cell-based E-cadherin dropped
down during the course of infection, but did not lead to a
complete cleavage, even at late time points of infection (8
hours). We therefore propose that cleavage of E-cadherin by
HtrA during infection is a strictly controlled, temporary and
locally restricted process, possibly achieved by surface-
exposed and/or secreted HtrA proteins when the bacteria
enter the intercellular space. Host cells continuously
translate large amounts of E-cadherin proteins, and there-
fore the host cell machinery could rapidly replace cleaved
proteins. This hypothesis could also explain why no signifi-
cant reduction in TER was observed during infection
with C. jejuni, and suggests that these bacteria can
close the “door” behind them, which appears as a
clever novel infection mechanism during bacterial
transmigration across polarised gut epithelial cells.
Methods
Campylobacter strains
The C. jejuni strains RM1221, ATCC43430, TGH-9011,
NCTC11168, 1849, 81–176, 1543/01, 2703/01, ST3046
and F38011 were used in this study. The isogenic mutants
81-176ΔcadF, 11168ΔhtrA and 11168htrAS197A were
recently described [33,35-37]. The isogenic F38011ΔcadF
and 81-176ΔflaA/B mutants were kindly provided by
Michael Konkel [57] and Patricia Guerry [58]. All C. jejuni
strains were grown on Campylobacter blood-free selective
Agar Base (Oxoid) containing Campylobacter growth
supplement (Oxoid) or on Mueller-Hinton (MH) agar
amended with 50 μg/ml kanamycin or 30 μg/ml or
chloramphenicol at 37°C under microaerobic conditions
(generated by CampyGen, Oxoid) for 48 hours.
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Salmonella typhimurium strain NCTC12023 was kindly
provided by M. Hensel (University Osnabrueck/Germany).
Neisseria gonorrhoeae strain 6B10 is a gift of T. Meyer (Max
Planck Institute for Infection Biology Berlin/Germany).
Shigella flexneri strain 15.4 is a clinical isolate from the
Medical School Magdeburg/Germany, and Listeria mono-
cytogenes strain EGD (Serotyp 1/2a) was kindly provided
by J. Wehland (HZI Braunschweig/Germany). As control,
we used the non-pathogenic Escherichia coli strain Top10
(Invitrogen). Each of these bacteria was grown overnight
at 37°C on conventional LB agar plates.
HtrA secretion assays
C. jejuni wild-type and ΔhtrA deletion mutant strains
were grown in BHI broth medium for 12 hours to an
OD600nm ~1.0. The supernatant and the cell pellets were
separated by centrifugation at 4,000 rpm, and the super-
natant was further purified from remaining bacterial cells
by passage through a 0.21 μm sterile filter. The resulting
bacterial pellets and supernatants were analysed by
immunoblot and casein zymography analyses. Absence
of live bacteria in the supernatant was confirmed by in-
cubation on agar plates showing no growth.
Motility assays
Motility phenotypes of strains were tested in MH media
containing 0.4% agar. Bacterial cells were harvested from a
36 h culture on conventional agar plates and resuspended in
PBS to obtain an optical density at 600 nm of 0.45 (approxi-
mately 1×109 CFU/ml). Subsequently, 2 μl of a bacterial
suspension of 2×108 CFU/ml were stabbed into motility
agar. Plates were incubated at 37°C under microaerophilic
conditions for 36 h, followed by measuring the diameter of
the resulting swarms. The final data were the mean of at
least five separate measurements from three experiments.
Host cell lines
Human embryonic intestinal epithelial cells (INT-407,
non-polarised), obtained from the American Type Cul-
ture Collection (ATCC CCL-6) and polarised MKN-28
cells were grown in RPMI-1640 medium containing L-
glutamine and Earle’s salts (Gibco). After reaching about
70% confluency, the cells were washed two times with
PBS, and then starved for 12 h before infection.
Infection studies
For the infection experiments, INT-407 cells were seeded
to give 4 × 105 CFU in 12-well tissue culture plates. The
culture medium was replaced with fresh medium with-
out antibiotics 1 h before infection. Bacteria were sus-
pended in culture medium, added to the cells at a
multiplicity of infection (MOI) of 100, and co-incubatedwith host cells for the indicated periods of time per
experiment.
Transepithelial electrical resistance (TER) assay
MKN-28 cells were cultured on 0.33 cm² cell culture
inserts with 3 μm pore size (Millipore). The cells were
allowed to form confluent monolayers, and then incu-
bated for another 14 days. TER was measured with an
Electrical Resistance System (ERS) (Millipore). Maximum
resistance indicated that the cells reached maximal po-
larity. TER was calculated as Ohms x cm² by subtracting
fluid resistance and multiplying by the monolayer surface
area. Bacteria were suspended in culture medium, added
to the cells at a multiplicity of infection (MOI) of 50,
and co-incubated with host cells for the indicated peri-
ods of time per experiment. The number of CFU was
determined by growth on MH or LB plates, respectively.
HtrA expression, purification and E-cadherin cleavage
in vitro
Cloning of H. pylori htrA (HpHtrA aa18-aa475) and C.
jejuni htrA (CjHtrA aa17-aa472) was described previ-
ously [33,34]. Briefly, the genes were amplified from gen-
omic DNA excluding predicted signal peptides. PCR
fragments flanked by restriction sites for BamHI/XmaI
were cloned into pGEX-6P-1 (GE Healthcare) to gener-
ate a GST-fusion protein. The expression and purifica-
tion protocol was described in detail [34]. Cleavage
assays of purified HtrA with recombinant human full-
length E-cadherin (R&D Systems), recombinant human
His-tagged N-terminal NTF domain (Sino Biological) or
human fibronectin (Calbiochem) were performed as
described [32].
SDS-PAGE and western blot
Cells were lysed [32], proteins were separated by SDS-PAGE
and tested for fibronectin (Santa Cruz) and E-cadherin using
polyclonal antibodies recognizing the extracellular domain
of E-cadherin (H-108 from Santa Cruz or HECD1 from BD
Biosciences) and whole cell lysates were tested for GAPDH.
The polyclonal anti-His tag antibody is from Qiagen and the
rabbit HtrA antibody was described in [36,37]. Bacterial
HtrAs were detected by Coomassie staining (BioRad).
Casein zymography
Bacterial lysates, culture supernatants or recombinant HtrA
were separated in casein containing gels under non-reducing
conditions. Subsequently, gels were renatured in 2.5% Tri-
ton-X-100 and equilibrated in developing buffer [34]. Casei-
nolytic activity was visualized by staining with 0.5%
Coomassie Blue R250.
Field emission scanning electron microscopy (FESEM)
Plate-grown C. jejuni strains were harvested and fixed in
a sterile solution containing 5% formaldehyde, 2%
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0.01 M CaCl2, 0.01 M MgCl2, 0.09 M sucrose, pH 6.9) for 1
hour on ice. The solution was centrifuged and passed
through a sterile filter. After several washes with cacodylate
buffer and TE buffer (20 mM Tris, 1 mM EDTA, pH 6.9),
samples were dehydrated in serial dilutions of acetone (10,
30, 50, 70, 90 and 100%) on ice for 15 min each step. Sam-
ples were then allowed to reach room temperature before
another change of 100% acetone, after which they were sub-
jected to critical-point drying with liquid CO2 (CPD030,
Bal-Tec). Samples were finally covered with ca. 10.0-nm 11
thick gold film by sputter coating (SCD500, Bal-Tec) and
examined in a field emission scanning electron microscope
(Zeiss DSM 982 Gemini) using an Everhart Thornley SE de-
tector and in-lens detector in a 50:50 ratio at an acceleration
voltage of 5.0 kV.Electron microscopic analysis by negative staining
For negative staining, thin carbon support films were
prepared by indirect sublimation of carbon on freshly
cleaved mica. Samples were then absorbed to the carbon
film and negatively stained with 1% (wt/vol) aqueous ur-
anyl acetate (pH 4.5). After air drying, samples were
examined by transmission electron microscopy (TEM) in
a Zeiss TEM 910 at an acceleration voltage of 80 kV.
Statistical analysis
All data were evaluated using Student t-test with SigmaStat
statistical software (version 2.0). Statistical significance was
defined by P≤ 0.05 (*) and P≤ 0.005 (**). All error bars
shown in figures and those quoted following the +/− signs
represent standard deviations.Additional file
Additional file 1: Figure S1. Structural and sequence comparison of
C. jejuni and H. pylori HtrA proteins. (A) Schematic diagram of the
domain arrangement of HtrAs from C. jejuni (Cj) and H. pylori (Hp). (B) Multiple
sequence alignment of HtrA from different C. jejuni and H. pylori strains. The
protein sequences of Cj 81–176, Cj RM1221, Cj NCTC11168, Hp 26695, Hp P12
and Hp 35A are aligned. The conserved amino acids of the catalytic triad are
indicated in red and shaded with yellow (H: Histidine; D: Aspartic acid; S: Serine).
Figure S2. Analysis of wild-type C. jejuni and htrAmutants by negative
staining and electron microscopy. Investigation revealed that wild-type (wt)
C. jejuni and different htrA mutants of strain 81–176 and NCTC11168 produce
intact bipolar flagella (blue arrows) and only slight morphological differences,
thus confirming results from FESEM (Figure 1). Each bar corresponds to 1 μm.
Figure S3. Overexpression and purification of C. jejuni HtrA. C. jejuni HtrA
was expressed as GST-tag fusion in E. coli BL-21, and then purified as described
in Materials and Methods. A Coomassie-stained gel of different fractions and
purified HtrA proteins during the purification procedure is shown. Figure S4.
Recombinant C. jejuni HtrA cleaves E-cadherin but not fibronectin at 42°C.
The experiments were performed under identical conditions as shown in
Figure 4D/E, but were incubated not incubated at 37°C but 42°C. (A) In vitro
cleavage of the recombinant E-cadherin NTF domain performed with purified Cj
HtrA or Hp HtrA results in several indicated subfragments. (B) In vitro cleavage
assay of fibronectin incubated with purified HtrAs under identical conditions
shows that fibronectin can be cleaved by Hp HtrA, but not Cj HtrA. All reactions
were incubated for 16 h.Competing interests
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